- Acronym:
- EurValve
- Logotyp:
-

- Full name:
- Personalised Decision Support for Heart Valve Disease
- Duration:
- 1.02.2016 - 31.01.2019
- Aim:
-
Valvular Heart Disease currently affects 2.5% of the population, but is overwhelmingly a disease of the elderly and consequently on the rise. It is dominated by two conditions, Aortic Stenosis and Mitral Regurgitation, both of which are associated with significant morbidity and mortality, yet which pose a truly demanding challenge for treatment optimisation.
By combining multiple complex modelling components developed in recent EC-funded research projects, a comprehensive, clinically-compliant decision-support system was developed to meet this challenge, by:- Quantifying individualised disease severity and patient impairment,
- Predicting disease progression,
- Ranking the effectiveness of alternative candidate procedures,
- Optimising the patient-specific intervention plan.
- Contact:
- Marian Bubak, e-mail: marian.bubak (at) cyfronet.pl, phone: (+48 12) 328 33 56
- More info:
- https://eurvalve.sites.sheffield.ac.uk/